However, it is considered a progression risk if detected and Stachler MD, et al. reported that TP53 mutations in BE tissues increased the adjusted risk of progression to high-grade dysplasia or EAC 13.8-fold (95% CI, 3.2–61.0)35. This evidence concerns the gene TP53 and Barrett esophagus.